Oppenheimer (OPY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for May 5, 2025, to be held virtually, with voting on director elections and auditor ratification.
Only Class B voting common stockholders may vote; Class A non-voting stockholders may attend and submit questions.
The company operates as a diversified financial services firm with global subsidiaries.
Voting matters and shareholder proposals
Stockholders will vote to elect nine directors and to ratify Deloitte & Touche LLP as auditors for 2025, with the Audit Committee authorized to set remuneration.
Board recommends voting FOR all director nominees and FOR auditor ratification.
No other matters are expected to be brought to a vote; proxies may vote on other business at their discretion.
Stockholder proposals for the 2026 meeting must be submitted by January 31, 2026.
Board of directors and corporate governance
Board consists of nine directors, seven of whom are independent as per NYSE rules.
Board committees include Audit, Compensation, Compliance, and Nominating and Corporate Governance, all composed of independent directors.
2024 attendance at board and committee meetings was 100% for all directors.
Board conducted annual self-assessment and reviewed governance guidelines.
Succession planning led to the announced transition of CEO role from A.G. Lowenthal to R.S. Lowenthal, effective after the 2025 meeting.
Latest events from Oppenheimer
- All proxy proposals are set for approval, with strong board governance and compensation oversight.OPY
Proxy Filing13 Mar 2026 - Annual meeting to vote on directors, auditors, executive pay, and charter changes, with all approvals expected.OPY
Proxy Filing2 Mar 2026 - Record 2024 results, leadership change, and all proposals approved amid market uncertainty.OPY
AGM 20253 Feb 2026 - Record 2025 earnings and revenue driven by robust Wealth Management and Capital Markets growth.OPY
Q4 202530 Jan 2026 - Q3 2025 revenue up 13.7% to $424.4M; net income down 11.4% on higher compensation costs.OPY
Q3 20253 Nov 2025 - Net income surged 111% year-over-year on strong revenue, record AUM, and robust trading.OPY
Q2 20251 Aug 2025 - Net income jumped 76.8% on record AUM, revenue, and improved segment performance.OPY
Q3 202413 Jun 2025 - Earnings rebounded to $10.3M on 8% revenue growth and record AUM.OPY
Q2 202413 Jun 2025 - Net income up 17.7% to $30.7M; record equity and CEO transition signal future growth.OPY
Q1 20256 Jun 2025